India Pesticides Q3FY26 Earnings Call Transcript Shows Strong Growth Performance
India Pesticides Limited released its Q3FY26 earnings call transcript showing exceptional financial performance with 31% revenue growth to ₹229 crores and 41% net profit increase to ₹23 crores. The company demonstrated strong operational efficiency with EBITDA margins improving to 18% and robust export growth of 28% driven by demand in Europe and Australia.
*this image is generated using AI for illustrative purposes only.
India Pesticides Limited has released the complete transcript of its Q3 FY26 earnings conference call held on February 11, 2026, showcasing robust financial performance for the quarter ended December 31, 2025. The company delivered strong growth across key metrics with significant improvements in both revenue and profitability.
Strong Q3 FY26 Financial Performance
The company reported impressive financial results for the third quarter, demonstrating consistent growth momentum and operational efficiency improvements.
| Financial Metrics: | Q3 FY26 | Q3 FY25 | Growth (%) |
|---|---|---|---|
| Total Revenue: | ₹229 crores | ₹175 crores | +31% |
| EBITDA: | ₹41 crores | ₹29 crores | +39.7% |
| EBITDA Margin: | 18% | 17% | +100 bps |
| Net Profit: | ₹23 crores | ₹16 crores | +41% |
| PAT Margin: | 10% | - | - |
Nine-Month Performance Highlights
For the nine-month period ended December 2025, India Pesticides demonstrated exceptional growth across all financial parameters, reflecting strong operational leverage and cost efficiency measures.
| 9M Performance: | FY26 | FY25 | Growth (%) |
|---|---|---|---|
| Total Revenue: | ₹808 crores | ₹633 crores | +27.6% |
| EBITDA: | ₹149 crores | ₹101 crores | +48% |
| Net Profit: | ₹89 crores | ₹62 crores | +44% |
Market Segmentation and Geographic Performance
The company maintained a balanced revenue mix with technical and API products contributing 73% and formulations accounting for 27% of Q3 FY26 revenue. Export sales showed robust growth of 28%, reaching ₹96 crores compared to ₹75 crores in Q3 FY25, driven by strong demand in Europe and Australia. Domestic sales increased by 33% to ₹130 crores, supported by higher demand for herbicides and intermediates.
Capacity Expansion and Strategic Initiatives
Management highlighted significant progress in capacity expansion initiatives. The Shalvis facility has commenced commercial production of technical products, with expectations to contribute ₹80 crores to ₹100 crores in revenue for the next financial year. The company's intermediate Pretilachlor PEDA plant has been commissioned with expanded capacity, with PEDA and Pretilachlor combined contributing ₹50 crores to ₹60 crores in Q3.
| Operational Updates: | Details |
|---|---|
| Current Capacity Utilization: | 65% for Q3 |
| Technical Capacity: | 29,000 tons (expanding from 28,200 tons) |
| Shalvis Revenue Target FY27: | ₹80-100 crores |
| Solar Power Supply: | 6 megawatt at Sandila unit |
Future Growth Roadmap
CEO D.K. Jain outlined the company's ambitious growth strategy, targeting ₹3,000 crores revenue by March 2031. The roadmap includes ₹1,000-1,100 crores from Hamirpur facility, ₹1,500 crores from existing Sandila and Dewa Road units, and ₹500 crores from B2C branded sales. For FY27, the company expects approximately 20% revenue growth while maintaining EBITDA margins in the 18-20% range.
Regulatory Compliance and Documentation
The earnings call transcript was submitted to BSE Limited and National Stock Exchange of India Limited on February 17, 2026, in compliance with Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The transcript is also available on the company's website at www.indiapesticideslimited.com , ensuring transparent communication with all stakeholders.
Historical Stock Returns for India Pesticides
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -4.42% | -7.75% | -14.85% | -33.71% | +12.13% | -58.71% |
19
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
